Feed MYO
MY

Myomo, Inc. MYO AMEX · Healthcare · United States

$0.92 -9.78% -$0.10

Summary

38 / 100 · Bulios Score

What speaks for it

  • Revenue grew by 38% a year over the last 3 years.
  • The share price is below the Bulios Fair Price.

What to watch

  • The company made a loss over the last 12 months.
  • It passes only 3 of the 9 points of the Piotroski financial health test.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks cheap
Bulios Fair Price
Undervalued Price today $0.92

By our assumptions the business is worth more than its shares cost today.

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

The company made a loss over the last 12 months, so there is no profit to set the price against.

Valuation in detail

Is it growing?

Yes, fast

Revenue (USD)

Diluted EPS (USD)

  • Analyst estimate

Revenue grew by 40% a year over 5 years. Over the last 3 years it grew by 38% a year.

Growth in detail

Does it make money?

Poorly

Over the last 12 months it made a loss of $15.1M.

Profitability in detail

Is it financially healthy?

Debt is a burden

Over the last 12 months it spent more cash than it brought in. Its debt is larger than its cash.

Financial health in detail

Does it pay a dividend?

No

It pays no dividend.

Dividends in detail

What do analysts expect?

Mildly positive

Today's price within the analysts' price targets

The average target of $3.45 is 275% above today's price. 88% of the analysts recommend buying.

Analysts in detail

What does it earn on?

Fiscal year 2024

By product

By region

The company reports no revenue by region.

Product brings in 100% of revenue.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy